PDF) Evaluation of the Disease Activity index for PSoriatic Arthritis (DAPSA) with a quick quantitative C reactive protein assay (Q-DAPSA) in patients with psoriatic arthritis: a prospective multicentre cross-sectional study
EMEUNET on Twitter: "🔔@ProftDr has been selected as one of our @EMEUNET Top 10 Abstracts at #ACR2021 This study investigates the possibility to calculate DAPSA with a quick Cup Test, which could
Validation of the Disease Activity Index for Psoriatic Arthritis (DAPSA) with a Quick QuantitativeC-reactive Protein Assay (Q-DAPSA) in Patients with Psoriatic Arthritis (PsA): A Prospective,national, Multicenter Study - ACR Meeting Abstracts
PDF) Application of composite disease activity scores in psoriatic arthritis to the PRESTA data set
Disease activity states of the DAPSA, a psoriatic arthritis specific instrument, are valid against functional status and structural progression | Annals of the Rheumatic Diseases
RheumaHelper
Disease Activity in Psoriatic Arthritis - DAPSA
Radiographic Progression in Psoriatic Arthritis Achieving a Good Response to Treatment: Data Using Newer Composite Indices of Disease Activity - Helliwell - 2018 - Arthritis Care & Research - Wiley Online Library
Disease Activity Scoring in Rheumatology | PDF | Arthritis | Rheumatoid Arthritis
DAPSA (Disease Activity in PSoriatic Arthritis) Score
MDA Versus DAPSA: Applicability in a Real World - ACR Meeting Abstracts
Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice | The Journal of Rheumatology
The state of the art—psoriatic arthritis outcome assessment in clinical trials and daily practice - The Lancet Rheumatology
Disease Activity Scoring in Rheumatology | PDF | Arthritis | Rheumatoid Arthritis
Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 study - ScienceDirect
Validation of the Disease Activity Index for Psoriatic Arthritis (DAPSA) with a Quick QuantitativeC-reactive Protein Assay (Q-DAPSA) in Patients with Psoriatic Arthritis (PsA): A Prospective,national, Multicenter Study - ACR Meeting Abstracts
Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis (COMPLETE-PsA): a double-blind, placebo-controlled, randomised, trial - The Lancet Rheumatology
Disease activity and response assessment in psoriatic arthritis using the Disease Activity index for PSoriatic Arthritis (DAPSA). A brief review. | Semantic Scholar
Very Low Disease Activity, DAPSA Remission, and Impact of Disease in a Spanish Population with Psoriatic Arthritis | The Journal of Rheumatology
Disease activity assessment in patients with psoriatic arthritis - ScienceDirect
Validation of the Disease Activity Index for PSoriatic Arthritis (DAPSA) with a quick quantitative C-reactive protein assay (Q-DAPSA) in patients with psoriatic arthritis (PsA) - GRAPPA Network
Disease activity categories by Q-DAPSA vs. DAPSA | Download Scientific Diagram
Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice | The Journal of Rheumatology
